Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 1,400 shares at $158.08 ($221K) on 2018-10-15, disclosed to the SEC on 2018-10-17.
Open-market sale of $221k JAZZ by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.08 | 700 | $111K | 50.0% |
| 2 | $158.08 | 700 | $111K | 50.0% |
| Total | $158.08 avg | 1,400 | $221K | 100% |
| Filing → |
| JAZZ | SELL | 2018-11-27 | $105K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |
| JAZZ | SELL | 2018-08-16 | $246K | — | Filing → |